Rare Genetic Deletion Linked to Heart Defect: What Parents Should Know
"A new case study highlights the connection between a specific genetic deletion (18q deletion syndrome) and a significant heart condition in newborns, offering critical insights for early diagnosis and care."
The 18q deletion syndrome is a rare genetic disorder, occurring in approximately 1 in 40,000 live births. This syndrome is characterized by the deletion of a portion of the long arm (q) of chromosome 18. While the size and location of the deletion can vary, leading to a wide range of symptoms, cardiac anomalies are frequently observed in affected individuals.
A recent case study published in the Annals of Laboratory Medicine details a newborn diagnosed with a de novo 18q22.1q23 deletion, meaning the deletion occurred spontaneously and was not inherited from either parent. What makes this case particularly noteworthy is the presence of a large atrial septal defect (ASD), a significant heart defect causing cyanosis (a bluish discoloration of the skin due to low oxygen levels).
This article aims to break down the key findings of this case study, explaining the connection between the 18q deletion syndrome and cardiac defects, particularly ASD. We will explore the diagnostic process, potential implications for affected children, and resources available for families.
Reported Heart Findings in Two Girls
A 2013 report described two girls with terminal 18q deletions and cardiac findings. One had Ebstein anomaly and Wolff–Parkinson–White syndrome; the other had multiple valve stenosis and a ventricular septal defect. The authors noted that genotype–phenotype correlations for cardiac anomalies in 18q deletion syndrome had rarely been reported.
Individualized Surveillance
The Proximal 18q- treatment and surveillance recommendations cover the population with proximal 18q deletions, while emphasizing that each person has a unique deletion. The syndrome’s phenotype is highly variable and can include impaired intellectual development, short stature, hypotonia, hearing impairment, and foot deformities. A guide identifies proactive management across body systems, including screening for structural heart defects linked to GATA6, as a priority.
Understanding 18q Deletion Syndrome and Its Impact on Heart Development
The 18q deletion syndrome can manifest in various ways, affecting multiple systems in the body. While each individual experiences a unique combination of symptoms, some common features include developmental delays, intellectual disability, characteristic facial features, and, as highlighted in this case study, cardiac anomalies.
- Atrial Septal Defect (ASD): A hole between the heart's upper chambers can cause oxygen-rich and oxygen-poor blood to mix.
- Ventricular Septal Defect (VSD): Similar to ASD, but the hole is between the lower chambers of the heart.
- Tetralogy of Fallot: A combination of four heart defects that restrict blood flow to the lungs.
- Pulmonary Stenosis: Narrowing of the pulmonary valve, making it harder for the heart to pump blood to the lungs.
A Developing Evidence Base
MediFind’s page, dated August 17, 2025, collects articles it describes as relevant to keeping up with research on distal 18q deletion syndrome. A 2019 clinical delineation of 18q11-q12 microdeletion reported two new patients and reviewed 27 additional cases in DECIPHER/ClinGen databases and four literature cases. The review describes distal deletion as the common classification and proximal interstitial deletion spanning 18q11.2-q21.1 as much rarer.
Variable Severity and Supportive Care
The severity and signs of proximal chromosome 18q deletion syndrome depend on the size and location of the deletion and which genes are affected. There is no cure for 18q deletion syndrome, and management is supportive and symptom-based. Reported interventions may include growth hormone therapy for short stature, hearing aids or surgery for hearing loss, cardiac surgery for congenital heart defects, orthopedic interventions, speech therapy, and educational support.
Heart Defects Across Deletion Reports
Reports describe varied congenital heart defects in people with 18q deletions, including anomalous pulmonary venous return, absent pulmonary valve, and Ebstein anomaly. A 2019 review of 18q11-q12 deletions reported conotruncal heart defects in 15% of cases and noted that four of five cases with cardiac defects had deletions distal to GATA6, suggesting another explanation may be involved. A report on atrial septal defect says the threshold for obtaining transesophageal echocardiography (TEE) should be low in patients with 18q− to support early recognition and treatment of structural heart disease.
What This Means for Families and Future Research
This case study underscores the importance of genetic testing in newborns presenting with unexplained cyanosis or suspected congenital anomalies. Early diagnosis of 18q deletion syndrome can facilitate timely intervention, including cardiac surgery to correct ASD and other associated health issues. Furthermore, understanding the specific genes involved in heart development within the 18q region can pave the way for targeted therapies and improved outcomes for affected individuals.
A Broad and Variable Outlook
Chromosome 18q- syndrome involves deletion of part of the long arm of chromosome 18. NORD describes associated symptoms and findings as varying greatly in range and severity from case to case. This variability underscores why the outlook cannot be reduced to a single expected presentation.
Individual Cases Reveal a Wide Spectrum
A 2022 report described a 22-month-old boy with 18q deletion syndrome who had a symptomatic pulmonary artery sling. The report notes that previously described congenital heart diseases most commonly included pulmonary valve anomalies and septal defects. A separate Korean case report said its findings supported a relationship between terminal 18q deletion and ASD and could inform further studies of genotype–phenotype correlations involving cardiac anomalies.